Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S T Chiang

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|April 1, 1982
Oxaprozin disposition in renal diseaseS T Chiang, G Morrison, J A Knowles, et al.
Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and ethanolS M Troy, M B Turner, M Unruh, et al.
Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxineS M Troy, V P Parker, D R Hicks, et al.
Journal of Clinical Pharmacology|August 1, 1984
Effects of food on oxaprozin bioavailabilityS T Chiang, J A Knowles, J A Hubsher, et al.
Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithiumS M Troy, V D Parker, D R Hicks, et al.
Journal of Clinical Pharmacology|May 1, 1991
The absolute bioavailability and dose proportionality of intravenous and oral dosage regimens of recainamS M Troy, W H Cevallos, K A Conrad, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
The effect of renal disease on the disposition of venlafaxineS M Troy, R W Schultz, V D Parker, et al.
Pharmacotherapy|September 1, 1996
Effects of age and gender on venlafaxine and O-desmethylvenlafaxine pharmacokineticsK J Klamerus, V D Parker, R L Rudolph, et al.
Hormone Research|January 1, 1987
Effects of thyroidectomy and thyroxine replacement on the release of luteinizing hormone and gonadotropin-releasing hormone in vitroS W Wang, H F Pu, S T Chiang, et al.
Pharmacotherapy|November 1, 1996
Pharmacokinetic-pharmacodynamic relationships of bromfenac in mice and humansS T Chiang, J C Ermer, M Osman, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|April 1, 1982
Oxaprozin disposition in renal diseaseS T Chiang, G Morrison, J A Knowles, et al.
Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and ethanolS M Troy, M B Turner, M Unruh, et al.
Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxineS M Troy, V P Parker, D R Hicks, et al.
Journal of Clinical Pharmacology|August 1, 1984
Effects of food on oxaprozin bioavailabilityS T Chiang, J A Knowles, J A Hubsher, et al.
Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithiumS M Troy, V D Parker, D R Hicks, et al.
Journal of Clinical Pharmacology|May 1, 1991
The absolute bioavailability and dose proportionality of intravenous and oral dosage regimens of recainamS M Troy, W H Cevallos, K A Conrad, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
The effect of renal disease on the disposition of venlafaxineS M Troy, R W Schultz, V D Parker, et al.
Pharmacotherapy|September 1, 1996
Effects of age and gender on venlafaxine and O-desmethylvenlafaxine pharmacokineticsK J Klamerus, V D Parker, R L Rudolph, et al.
Hormone Research|January 1, 1987
Effects of thyroidectomy and thyroxine replacement on the release of luteinizing hormone and gonadotropin-releasing hormone in vitroS W Wang, H F Pu, S T Chiang, et al.
Pharmacotherapy|November 1, 1996
Pharmacokinetic-pharmacodynamic relationships of bromfenac in mice and humansS T Chiang, J C Ermer, M Osman, et al.
Pageof 8